NCT00200447View on ClinicalTrials.gov

An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Parkinson's Disease
Interventions
DRUG

carbidopa/l-dopa

DRUG

carbidopa/l-dopa/entacapone

DRUG

Stalevo

PROCEDURE

[123I]-IBZM imaging

Sponsors
All Listed Sponsors
lead

Molecular NeuroImaging

OTHER